🇪🇺·6d agoResearchTier 2 · Direct publisher
Antibody-drug conjugate engineering: from design to efficacy and safety.
Publisher
E
Europe PMC
EU
This page provides publisher metadata, and related coverage to support discovery before sending readers to the publisher's original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- September 23, 2026
- Language
- EN
Publisher context, original article off-platform
This page presents the title, publisher metadata, and related coverage. The publisher did not provide a public summary in this feed. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Evidence: Tier 2 · Direct publisher
Related coverage
More related coverage
Universitätsspital Zürich (USZ)/19h ago
Accela – Linearbeschleuniger
CU Anschutz Medical/17h ago
AB Nexus Awards $825,000 to Five CU Anschutz-CU Boulder Research Teams
UNLP Health Sciences/17h ago
Nueva línea universitaria de colaciones saludables
UNLP Health Sciences/17h ago